BillionToOne, Inc. (BLLN)
NASDAQ: BLLN · Real-Time Price · USD
85.42
-5.00 (-5.53%)
At close: Feb 20, 2026, 4:00 PM EST
85.52
+0.10 (0.12%)
After-hours: Feb 20, 2026, 4:59 PM EST
BillionToOne Revenue
BillionToOne had revenue of $83.52M in the quarter ending September 30, 2025, with 141.79% growth. This brings the company's revenue in the last twelve months to $254.14M. In the year 2024, BillionToOne had annual revenue of $152.58M with 112.72% growth.
Revenue (ttm)
$254.14M
Revenue Growth
+112.72%
P/S Ratio
15.38
Revenue / Employee
$409,897
Employees
620
Market Cap
3.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 152.58M | 80.85M | 112.72% |
| Dec 31, 2023 | 71.73M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBLLN News
- 4 days ago - BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - GlobeNewsWire
- 11 days ago - BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select® - PRNewsWire
- 12 days ago - BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care - PRNewsWire
- 5 weeks ago - BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare - PRNewsWire
- 5 weeks ago - BillionToOne Provides Guidance for 2026 - GlobeNewsWire
- 6 weeks ago - BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East - PRNewsWire
- 2 months ago - BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - BillionToOne, Inc. (BLLN) Q3 2025 Earnings Call Transcript - Seeking Alpha